SYNTEGRA Trademark

Trademark Overview

On Friday, January 12, 2007, a trademark application was filed for SYNTEGRA with the United States Patent and Trademark Office. The USPTO has given the SYNTEGRA trademark a serial number of 77082341. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 15, 2010. This trademark is owned by NPS Pharmaceuticals, Inc.. The SYNTEGRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management
syntegra

General Information

Serial Number77082341
Word MarkSYNTEGRA
Filing DateFriday, January 12, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 15, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 19, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNPS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameNPS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events

Event DateEvent Description
Monday, November 15, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 15, 2010ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 16, 2010EXTENSION 5 GRANTED
Friday, February 19, 2010EXTENSION 5 FILED
Friday, February 19, 2010PAPER RECEIVED
Wednesday, August 26, 2009EXTENSION 4 GRANTED
Monday, August 17, 2009EXTENSION 4 FILED
Monday, August 17, 2009PAPER RECEIVED
Wednesday, February 25, 2009EXTENSION 3 GRANTED
Thursday, February 19, 2009EXTENSION 3 FILED
Thursday, February 19, 2009PAPER RECEIVED
Wednesday, November 19, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 19, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 18, 2008EXTENSION 2 GRANTED
Tuesday, September 9, 2008EXTENSION 2 FILED
Thursday, September 18, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 9, 2008PAPER RECEIVED
Wednesday, April 23, 2008EXTENSION 1 GRANTED
Thursday, April 10, 2008EXTENSION 1 FILED
Thursday, April 10, 2008PAPER RECEIVED
Tuesday, October 16, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2007NOTICE OF PUBLICATION
Wednesday, May 9, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 9, 2007ASSIGNED TO LIE
Thursday, April 19, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 4, 2007EXAMINER'S AMENDMENT ENTERED
Wednesday, April 4, 2007EXAMINERS AMENDMENT E-MAILED
Wednesday, April 4, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 4, 2007ASSIGNED TO EXAMINER
Friday, January 19, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

syntegra disorders diseases pharmaceutical cells preparations endocrine system nervous bone metabolism